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Discussion After the Speeches of Mr. Frazza, Mr. Thomas
and Mr. Stayin
QUESTION, Professor King: Johnson & Johnson is a worldwide
company. It operates in many countries of the world. Is there any ten-
dency for companies, such as your own, to try new products overseas
first, because of fewer legal consequences? Are we being denied any
products because of our legal system here?
ANSWER, Mr. Frazza: I think it is a fact that around the world
there are many health products being sold that are not sold in the United
States. The major reason, though, is not product liability. It is the regu-
latory system. The FDA takes an enormous amount of time to approve
products and is so tied up with the political process, that they are very
timid in approving new products. As a result, there is a drug lag of any-
where from twelve to eighteen months. Now, it is not universal, there
are some products which come out here first.
But again, the regulatory agencies may reflect the mentality of the
country, and in our effort to eliminate risk, we sometimes keep very valu-
able life-saving products off the market.
COMMENT, Mr. Stayin: One of the problems that a U.S. manufac-
turer has is that his product liability costs do not decrease when he ex-
ports products. Even though he is selling to foreign markets, the
insurance companies charge him for the insurance on those products at
the same rate they charge in the U.S. market. The reason for this is the
fear that the manufacturer will be sued in the United States for accidents
that happen in other countries.
I was talking to a group of Swiss manufacturers two weeks ago, and
they agreed with my assessment of the problem and that it is a competi-
tive advantage for a foreign producer vis-a-vis U.S. firms. They said that
one of the impacts on Swiss companies who opened manufacturing facili-
ties in the United States was that lawsuits were being filed against them
in the United States for injuries in other parts of the world caused by
products sold and manufactured by their facilities outside the United
States. All these cases are coming here because we have this system with
big rewards.
COMMENT, Mr. Frazza: I agree with Mr. Thomas' earlier remarks
about the difference in the litigious mentality and the quality of state
judges. I do not entirely agree with him concerning the nexus between
social welfare and lawsuits.
Our studies indicate that most of the lawsuits do not come from the
lower-strata, uninsured part of the population. They normally come
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from people who are insured. In fact, in a U.S. court you cannot even
introduce the fact that the plaintiff has insurance. You can try a whole
case without the jury ever knowing that.
I see no correlation between the lack of insurance and the lawsuit. I
see upper-middle class claimants more than people from the South
Bronx. I think anybody who operates in drug product liability will con-
firm that. This is probably because upper-middle class claimants are
more informed. They may have a cousin who is a lawyer and they talk at
cocktail parties. Maybe we should have better social welfare systems. I
am not arguing with that, I am just arguing with the nexus between the
two.
QUESTION, Mr. Reifsnyder: Bruce Thomas mentioned the pos-
sibilities in Canada for recovering costs in various kinds of cases, but
what are the standard fee arrangements for attorney's fees in Canada?
Are there contingency fees?
ANSWER, Mr. Thomas: Well, not if it is the well-heeled client that
we have just heard about, it sure isn't. You are not going to act on a
contingency basis for somebody who has plenty of dollars. You are go-
ing to act for him on the basis of time, and our fees in Canada are far
lower than they should be.
It is not unusual, if you have an unsophisticated litigant, to finish
the claim, collect your quarter million dollars for that person, and send
him a bill for $50,000, to which he responds, "Fifty thousand dollars for
that? That is far too much." So he goes down to a court officer and has
the bill either taxed or assessed. You have to justify that bill and it is
then assessed. The normal considerations are the amount of time in-
volved, the complexity of the matter, the results in the case, the amount
recovered for the client and various considerations that would be com-
mon sense to any person. The bill is looked at in that light. If the client
is not happy, you must justify your bill. You may take half a day to do
it, but that is our procedure.
QUESTION, Mr. Mackey: I have two questions. First, is there an
EC regulation on product liability? Possibly our guest from the Commis-
sion would care to comment on that. Second, what is the assessment of
the strength of consumer lobbies and other lobbies that would be op-
posed to a national regulation on product liability and national law on
product liability?
ANSWER, Mr. Stayin: A product liability directive was passed in
the European Community. Each of the countries then had a few items
on which they could vote, such as whether to allow the state-of-the-art
defense. I understand that has been adopted in one way or the other, and
that they have met their deadline.
With respect to the strength of the consumer lobby in Washington, I
think they hurt themselves badly by lobbying their own consumer sup-
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porters over this bill, because they lied to them. They manipulated them
and they lost a lot of support there.
The consumer lobby is strong, but it is the trial lawyers that are the
most well-funded. They spend about $1.5 million each election cycle on
their political action committee funding for Members of Congress who
support their positions and they are very well organized. They are the
biggest problem.
Labor is playing a kind of a game with us. They say "We would like
to have some improvements. Let's have a national workers' compensa-
tion system. Let's do something with occupational disease. You can't do
product liability reform and ignore all these other problems in the work-
place." They are playing a bargaining game, trying to get a compromise
deal from the business community. I do not think they really care that
much about product liability. They are sometimes for it, sometimes
against it.
It is difficult. Product liability reform is perceived by consumer
groups and trial lawyers as taking rights away from consumers. They are
worried that they are not going to be able to bring lawsuits and that all
these injured parties will not be compensated and will have no way to
take care of themselves. It is not true.
We are trying to bring the balance back. We are not even going as
far as Canada in having a negligence standard. Overall the bill is much
more balanced than our current system. It falls somewhere on a contin-
uum between strict liability and the negligence standard.
QUESTION, Mr. Delay. In light of the Bankers Life v. Crenshaw
decision, which touched upon punitive damages, and the fact that the
U.S. Supreme Court has accepted a number of cases in this term on puni-
tive damages, do you think it is likely that the U.S. Supreme Court will
strike down punitive damages as unconstitutional?
ANSWER, Mr. Frazza: I do not think they will strike them in their
entirety. I do think that they will restrict them in some way. In other
words, should there be a proportionality between the compensatory dam-
ages and punitive damages or are there certain types of conduct that
never should be subject to punitive damages? I think there will be a
number of Supreme Court cases in the next five or six years that address
specific issues, but I very much doubt that punitive damages will be
abolished.
What we are really talking about is the quality of decision-making.
In other words, even if the jury is instructed that they must find the
conduct to be willful, wanton or malicious, the jury still can find virtually
any conduct which they consider negligent to be willful, wanton or mali-
cious. Somehow the Court will have to rein in the ability of juries to just
indiscriminately determine what is malicious conduct. However, I do
not think that they will abolish punitive damages as being
unconstitutional.
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QUESTION, Mr. Thomas: If you have 3500 people who have all
been injured as a result of something, how can you get that defendant
punished 3500 times with punitive damages? Can somebody explain the
rationale of that to me?
ANSWER, Mr. Frazza: That was just addressed in a case involving
asbestos in New Jersey. Judge Sarokin said that punitive damages were
meant to punish, not to execute. The National Tort Commission of the
ABA is proposing that in mass tort cases there be only one punitive dam-
age award. The ABA will vote on that in August in the form of a statute
to be proposed. I do not know whether it will ever get anywhere. If the
ABA approves it, it will be significant that the lawyers group is saying
"We only want one punitive damage award."
COMMENT, Professor King: Those proposals have had trouble in
the ABA because of the diverse interests of the lawyers for plaintiffs and
defendants.
COMMENT, Mr. Allen: There are a few additional differences be-
tween the two systems. One is the very limited availability in Canada of
class actions, whereas many U.S. actions are class actions. The other is
the very reduced legal process in Canada, which is particularly limited
with respect to pre-trial depositions. So the result is not necessarily to
reduce the number of cases, but to substantially reduce the expense and
the exercise.
COMMENT, Dr. Strub: Going back to the question on the EC
product liability regulations, it should be added that the regulations of
the Common Market have moved in the direction of more protection of
the consumer. It is enhancing innovation rather than blocking it. The
real effect is not in the legislation, but in the decision-making and in the
legal procedures. One should not confuse somewhat more consumer-
friendly legislation with a totally inadequate system of justice. In Europe
only the first one has been addressed.
COMMENT, Professor Shanker: I think there is something unreal
about what is being said here. Twenty-five years ago we did not have this
situation. The two countries were basically the same in terms of product
liability.
I think we are overlooking the fact that U.S. society is not so much
for a riskless society, but rather against risks that you have to pay for
yourself. It is really the idea that there has to be a payment for every
injury. The judges created that situation. We blame the jury, we blame
the trial lawyers. The judges have been the real innovators in this prod-
uct liability situation.
Even with all the new statutes we forget the ingenuity of the judges.
We have had statutes before that tried controlling that area, for example,
the Uniform Commercial Code, a complete product liability statute.
U.S. lawyers know how innovative judges can be in this area. So what
really has to happen is not these structural changes that are being pro-
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posed. A message must get across to the judges who make the decisions
that they went off in their own direction. I think they need to come back
a little bit.
Much of products liability is saying that people get hurt by living, by
being exposed to products. Somebody will pay for it. It can be the peo-
ple themselves, their families or the welfare system. Recently in the
United States, the trend has become to say, let the company pay for it.
But you have to ask yourself, how do you best compensate the victim?
Can you just simply cut back the liability of the business person? People
are going to get hurt in society. What is the best way to compensate for
these injuries?
The present product liability system in the United States is probably
the most cost ineffective system for compensating injured people. Is
there some better, more sensible way of compensating people? If so, how
do you do it?
COMMENT, Mr. Frazza: I could not agree more. I think the issue
is that the present system does not compensate fairly. It is uneven. It
does not compensate in a principled or predictable way. It gives the
manufacturer no guidance at all as to what conduct is undesirable and it
gives the participant in the system no guarantee of anything. Whether
there is another way to do it is the subject here tonight.
QUESTION, Mr. Thomas: Are we prepared to pay for a social wel-
fare system?
ANSWER, Mr. Frazza: I reject the fact that a "social welfare sys-
tem" is necessarily the way to compensate people. For example, in the
pharmaceutical industry, you could put a penny a pill in a pot, and eve-
ryone that gets hurt from whatever pharmaceutical would be able to, for
example, open a book and see how much they will get for a deformed
arm at a certain age. That sounds very simple. We have done it with
vaccine. But 3-7% percent of the population are born with birth defects
of some sort, and a mother might have taken twenty-six different drugs
during her life. Eighteen of these drugs may cause chromosomal dam-
age, then you get down to who pays, and how much, and whether or not
that is the way you want to do it. The problems seem simple.
I agree that people in a complicated industrial society are going to
be injured. We have to find a way to meet that need. There is no ques-
tion about it. Until we meet it, we are going to have trouble.
COMMENT Mr. Stayin: If we cannot resolve this through some
sort of a federal product liability reform, and if the system continues to
get worse, we may ultimately have to adopt some sort of a national com-
pensation system.
If you think about it, we are already paying $32 billion to $80 billion
out of our GNP, and that is not productive. We are already paying a tax
for this system, but we are paying a tax for a very inefficient means of
compensating individuals. There is plenty of room for dealing with com-
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pensation if you eliminate all these transaction costs. That may ulti-
mately be where we will end up.
COMMENT, Professor King: We have not found the solution yet,
but at least we have food for thought.
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